Recruiting

Steroid Injections for Light-Damaged Retinas

Plain-English translation of NCT07869511 on ClinicalTrials.gov ↗ · Source last updated October 2026 · Translation generated October 2026 · How we translate trials

What is this trial?

This is a retrospective study—meaning researchers will review medical records of patients who already experienced retinal damage from exposure to intense light (like from welding, looking at the sun, or similar sources). The study compares two groups: those who received glucocorticoid injections (a type of steroid) behind the eye, and those who did not receive this treatment. Researchers want to understand whether this medication helps restore vision and heal the damaged retina tissue.

Retinal light damage can cause vision problems and changes in the back of the eye, but doctors don't yet have a clear treatment standard. This study aims to find out whether steroid injections might help patients recover vision and repair retinal damage better than receiving no specific treatment.

Do you qualify?

You likely qualify if…

you have been diagnosed with retinal damage from exposure to bright light, confirmed by eye exams and imaging
your damage shows specific patterns of injury in the central part of your retina (the macula), seen on advanced eye imaging scans
you experienced symptoms like blurred vision or distorted vision (wavy lines) after the light exposure
you are willing to sign consent forms and follow study procedures
you can attend follow-up visits for up to 6 months

You likely don't qualify if…

you have other eye diseases like glaucoma, uveitis, retinal detachment, or diabetic eye damage that would interfere with the study
you have had eye surgery or serious eye injury in the past
you have severe health conditions like heart disease, stroke, bleeding disorders, or brain surgery history
you are pregnant, planning to become pregnant, breastfeeding, or have a history of drug or alcohol abuse
you are currently enrolled in another drug trial or cannot cooperate with eye exams

What participation looks like

This is a retrospective study, so you won't receive a new treatment—researchers will review your existing medical records and eye imaging from before and after any treatment you already had. You may be asked to visit the clinic for up to 6 months so doctors can check your vision, take photographs of the back of your eye, and perform advanced imaging scans (OCT and OCTA) to track any changes in your retina. No additional injections or medications will be given specifically for this study.

AI-generated summary from trial data · Oct 12, 2026 · Not medical advice

Trial locations(1 site)

China

Second Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, Zhejiang